
Latest
Viatris Pacira Acquisition Values Drugmaker at $1.65 Billion
The Viatris Pacira acquisition values Pacira at $1.65 billion, offering shareholders $36.50 per share in cash subject to closing conditions.

The Viatris Pacira acquisition values Pacira at $1.65 billion, offering shareholders $36.50 per share in cash subject to closing conditions.